Overview · Full Intel report in progress

Play Store →

Patient Controller RC - US is an established medical app that is completely free. With a 3.0/5 rating from 129 reviews, it shows polarized user reception.

What is Patient Controller RC - US?

Patient Controller RC - US is a medical application developed by Abbott that enables patients to manage their Eterna™ Spinal Cord Stimulation and Liberta RC™ DBS systems. The app utilizes Bluetooth® technology to allow users to adjust stimulation settings and monitor device status directly from their mobile devices.

Current Momentum

v2.0 · 12mo ago

Zombie

Last updated 369d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Stimulation ManagementStandard

Allows users to turn stimulation ON/OFF and select specific programs to meet their therapy needs.

Amplitude AdjustmentStandard

Provides the ability to manually adjust stimulation amplitude levels.

Device MonitoringStandard

Enables users to check their implanted stimulator's battery status and monitor the charging process.

How much does it cost?

Free

Who Built It?

Abbott

(1.3K)

Providing integrated digital interfaces for medical devices and metabolic health tracking to improve patient outcomes and clinical data access.

Portfolio

13

Apps

Free 12
Medical58%
Business25%
Lifestyle8%

Who is Abbott?

Abbott occupies a specialized position where mobile software serves as a critical, regulated interface for proprietary medical hardware, such as cardiac monitors and neurostimulators. Their moat is built on deep clinical integration and regulatory clearances that are difficult for pure-play software competitors to replicate. The recent launch of Lingo marks a strategic expansion into the consumer biowearable market, testing whether their clinical credibility can capture the broader metabolic health category.

Who is Abbott for?

  • Patients with implanted cardiac or neuromodulation devices
  • Medical professionals performing structural heart interventions
  • Health-conscious consumers
Active

Portfolio momentum

The publisher released 7 updates in the last 6 months, with a major release occurring just 2 days ago, indicating high current development focus on their active titles.

Last release · 2d agoActive apps · 4Abandoned · 5

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for Patient Controller RC - US?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for Patient Controller RC - US

Key Takeaways

While the app provides essential therapy management, users frequently report significant frustration regarding the lack of compatibility with newer iOS device models.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by Patient Controller RC - US, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “Patient Controller RC - US Intelligence Report.” Updated Apr 19, 2026. https://marlvel.ai/intel-report/medical/patient-controller-rc-us

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0